This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bai X, Scheutz F, Dahlgren HM, Hedenström I, Jernberg C. Characterization of clinical Escherichia coli strains producing a novel Shiga toxin 2 subtype in Sweden and Denmark. Microorganisms. 2021 Nov;9(11):2374. https://doi.org/10.3390/microorganisms9112374BaiXScheutzFDahlgrenHMHedenströmIJernbergC.Characterization of clinical Escherichia coli strains producing a novel Shiga toxin 2 subtype in Sweden and Denmark..2021Nov;9(11):2374. https://doi.org/10.3390/microorganisms9112374Open DOISearch in Google Scholar
Bibbal D, Ruiz P, Sapountzis P, Mazuy-Cruchaudet C, Loukiadis E, Auvray F, Forano E, Brugère H. Persistent circulation of entero-hemorrhagic Escherichia coli (EHEC) O157:H7 in cattle farms: Characterization of enterohemorrhagic Escherichia coli O157:H7 strains and fecal microbial communities of bovine shedders and non-shedders. Front Vet Sci. 2022 Mar;9:852475. https://doi.org/10.3389/fvets.2022.852475BibbalDRuizPSapountzisPMazuy-CruchaudetCLoukiadisEAuvrayFForanoEBrugèreH.Persistent circulation of entero-hemorrhagic Escherichia coli (EHEC) O157:H7 in cattle farms: Characterization of enterohemorrhagic Escherichia coli O157:H7 strains and fecal microbial communities of bovine shedders and non-shedders..2022Mar;9:852475. https://doi.org/10.3389/fvets.2022.852475Open DOISearch in Google Scholar
Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: A microbiological study. Lancet Infect Dis. 2011 Sep;11(9):671–676. https://doi.org/10.1016/S1473-3099(11)70165-7BielaszewskaMMellmannAZhangWKöckRFruthABauwensAPetersGKarchH.Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: A microbiological study..2011Sep;11(9):671–676. https://doi.org/10.1016/S1473-3099(11)70165-7Open DOISearch in Google Scholar
Bitzan M. Treatment options for HUS secondary to Escherichia coli O157:H7. Kidney Int Suppl. 2009 Feb;(112):62–66. https://doi.org/10.1038/ki.2008.624BitzanM.Treatment options for HUS secondary to Escherichia coli O157:H7..2009Feb;(112):62–66. https://doi.org/10.1038/ki.2008.624Open DOISearch in Google Scholar
Bouzari S, Farhang E, Hosseini SM, Alikhani MY. Prevalence and antimicrobial resistance of shiga toxin-producing Escherichia coli and enteropathogenic Escherichia coli isolated from patients with acute diarrhea. Iran J Microbiol. 2018 Jun;10(3):151–157.BouzariSFarhangEHosseiniSMAlikhaniMY.Prevalence and antimicrobial resistance of shiga toxin-producing Escherichia coli and enteropathogenic Escherichia coli isolated from patients with acute diarrhea..2018Jun;10(3):151–157.Search in Google Scholar
Chen ML, Hao Z, Tian Y, Zhang QY, Gao PJ, Jin JL. Different effects of six antibiotics and ten traditional Chinese medicines on Shiga toxin expression by Escherichia coli O157:H7. Evid Based Complement Alternat Med. 2013;2013:121407. https://doi.org/10.1155/2013/121407ChenMLHaoZTianYZhangQYGaoPJJinJL.Different effects of six antibiotics and ten traditional Chinese medicines on Shiga toxin expression by Escherichia coli O157:H7..2013;2013:121407. https://doi.org/10.1155/2013/121407Open DOISearch in Google Scholar
Contreras CA, Ochoa TJ, Ruiz J, Lacher DW, Rivera FP, Saenz Y, Chea-Woo E, Zavaleta N, Gil AI, Lanata CF, et al. Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children. J Med Microbiol. 2011 May;60(Pt_5):639–646. https://doi.org/10.1099/jmm.0.026666-0ContrerasCAOchoaTJRuizJLacherDWRiveraFPSaenzYChea-WooEZavaletaNGilAILanataCF.Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children..2011May;60(Pt_5):639–646. https://doi.org/10.1099/jmm.0.026666-0Open DOISearch in Google Scholar
ECDC. STEC infection. In: ECDC. Annual epidemiological report for 2021. Stockholm (Sweden): European Centre for Disease Prevention and Control; 2022 [cited 2023 Oct 30]. Available from https://www.ecdc.europa.eu/sites/default/files/documents/AER%20STEC%20-%202021.pdfECDC.STEC infection. In:.Stockholm (Sweden):European Centre for Disease Prevention and Control;2022[cited 2023 Oct 30].Available from https://www.ecdc.europa.eu/sites/default/files/documents/AER%20STEC%20-%202021.pdfSearch in Google Scholar
EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0. Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; 2022.EUCAST. The European Committee on Antimicrobial Susceptibility Testing.. Version 12.0.Basel (Switzerland):The European Committee on Antimicrobial Susceptibility Testing;2022.Search in Google Scholar
Fatima R, Aziz M. Enterohemorrhagic Escherichia coli. [Internet, updated 2023 Jun 26]. Treasure Island (USA): StatPearls Publishing; 2023 [cited 2023 Oct 30]. Available from https://www.ncbi.nlm.nih.gov/books/NBK519509FatimaRAzizM..Treasure Island (USA):StatPearls Publishing;2023[cited 2023 Oct 30].Available from https://www.ncbi.nlm.nih.gov/books/NBK519509Search in Google Scholar
Harkins VJ, McAllister DA, Reynolds BC. Shiga-toxin E. coli Hemolytic Uremic Syndrome: Review of management and longterm outcome. Curr Pediatr Rep. 2020;8:16–25. https://doi.org/10.1007/s40124-020-00208-7HarkinsVJMcAllisterDAReynoldsBC.Shiga-toxin E. coli Hemolytic Uremic Syndrome: Review of management and longterm outcome..2020;8:16–25. https://doi.org/10.1007/s40124-020-00208-7Open DOISearch in Google Scholar
Hermos CR, Janineh M, Han LL, McAdam AJ. Shiga toxin-producing Escherichia coli in children: Diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol. 2011 Mar;49(3):955–959. https://doi.org/10.1128/jcm.02119-10HermosCRJaninehMHanLLMcAdamAJ.Shiga toxin-producing Escherichia coli in children: Diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection..2011Mar;49(3):955–959. https://doi.org/10.1128/jcm.02119-10Open DOISearch in Google Scholar
Herold S, Karch H, Schmidt H. Shiga toxin-encoding bacteriophages – genomes in motion. Int J Med Microbiol. 2004 Sep; 294 (2–3):115–121. https://doi.org/10.1016/j.ijmm.2004.06.023HeroldSKarchHSchmidtH.Shiga toxin-encoding bacteriophages – genomes in motion..2004Sep;294(2–3):115–121. https://doi.org/10.1016/j.ijmm.2004.06.023Open DOISearch in Google Scholar
Hua Y, Chromek M, Frykman A, Jernberg C, Georgieva V, Hansson S, Zhang J, Marits AK, Wan C, Matussek A, et al. Wholegenome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden. Virulence. 2021 Dec;12(1):1296–1305. https://doi.org/10.1080/21505594.2021.1922010HuaYChromekMFrykmanAJernbergCGeorgievaVHanssonSZhangJMaritsAKWanCMatussekA.Wholegenome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden..2021Dec;12(1):1296–1305. https://doi.org/10.1080/21505594.2021.1922010Open DOISearch in Google Scholar
Januszkiewicz A, Rastawicki W. Molecular characterization of Shiga toxin-producing Escherichia coli strains isolated in Poland. Pol J Microbiol. 2016 Aug;65(3):261–269. https://doi.org/10.5604/17331331.1215601JanuszkiewiczARastawickiW.Molecular characterization of Shiga toxin-producing Escherichia coli strains isolated in Poland..2016Aug;65(3):261–269. https://doi.org/10.5604/17331331.1215601Open DOISearch in Google Scholar
Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008 – A retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis. 2014 May; 14:265. https://doi.org/10.1186/1471-2334-14-265JenssenGRHovlandEBjerreABangstadHJNygardKVoldL.Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008 – A retrospective study of hospital records to assess the sensitivity of surveillance..2014May;14:265. https://doi.org/10.1186/1471-2334-14-265Open DOISearch in Google Scholar
Kagkli DM, Weber TP, Van den Bulcke M, Folloni S, Tozzoli R, Morabito S, Ermolli M, Gribaldo L, Van den Eede G. Application of the modular approach to an in-house validation study of realtime PCR methods for the detection and serogroup determination of verocytotoxigenic Escherichia coli. Appl Environ Microbiol. 2011 Oct;77(19):6954–6963. https://doi.org/10.1128/aem.05357-11KagkliDMWeberTPVan den BulckeMFolloniSTozzoliRMorabitoSErmolliMGribaldoLVan den EedeG.Application of the modular approach to an in-house validation study of realtime PCR methods for the detection and serogroup determination of verocytotoxigenic Escherichia coli..2011Oct;77(19):6954–6963. https://doi.org/10.1128/aem.05357-11Open DOISearch in Google Scholar
Kawamori F, Hiroi M, Harada T, Ohata K, Sugiyama K, Masuda T, Ohashi N. Molecular typing of Japanese Escherichia coli O157: H7 isolates from clinical specimens by multilocus variable-number tandem repeat analysis and PFGE. J Med Microbiol. 2008 Jan; 57(Pt_1): 58–63. https://doi.org/10.1099/jmm.0.47213-0KawamoriFHiroiMHaradaTOhataKSugiyamaKMasudaTOhashiN.Molecular typing of Japanese Escherichia coli O157: H7 isolates from clinical specimens by multilocus variable-number tandem repeat analysis and PFGE..2008Jan;57(Pt_1):58–63. https://doi.org/10.1099/jmm.0.47213-0Open DOISearch in Google Scholar
Kikuchi K, Lee K, Ueno H, Tomari K, Kobori S, Kaetsu A, Matsui M, Suzuki S, Sekizuka T, Kuroda M, et al. Enterohaemorrhagic Escherichia coli O121:H19 acquired an extended-spectrum β-lactamase gene during the development of an outbreak in two nurseries. Microb Genom. 2019 Jul;5(7):e000278. https://doi.org/10.1099/mgen.0.000278KikuchiKLeeKUenoHTomariKKoboriSKaetsuAMatsuiMSuzukiSSekizukaTKurodaM.Enterohaemorrhagic Escherichia coli O121:H19 acquired an extended-spectrum β-lactamase gene during the development of an outbreak in two nurseries..2019Jul;5(7):e000278. https://doi.org/10.1099/mgen.0.000278Open DOISearch in Google Scholar
Koyanagi Y, Suzuki R, Ihara K, Miyagi H, Isogai H, Yoneyama H, Isogai E. Intestinal Clostridium species lower host susceptibility to enterohemorrhagic Escherichia coli O157:H7 infection. Pathog Dis. 2019 Jun;77(4):ftz036. https://doi.org/10.1093/femspd/ftz036KoyanagiYSuzukiRIharaKMiyagiHIsogaiHYoneyamaHIsogaiE.Intestinal Clostridium species lower host susceptibility to enterohemorrhagic Escherichia coli O157:H7 infection..2019Jun;77(4):ftz036. https://doi.org/10.1093/femspd/ftz036Open DOISearch in Google Scholar
Kurabayashi K, Tanimoto K, Fueki S, Tomita H, Hirakawa H. Elevated expression of GlpT and UhpT via FNR activation contributes to increased fosfomycin susceptibility in Escherichia coli under anaerobic conditions. Antimicrob Agents Chemother. 2015 Oct;59(10):6352–6360. https://doi.org/10.1128/aac.01176-15KurabayashiKTanimotoKFuekiSTomitaHHirakawaH.Elevated expression of GlpT and UhpT via FNR activation contributes to increased fosfomycin susceptibility in Escherichia coli under anaerobic conditions..2015Oct;59(10):6352–6360. https://doi.org/10.1128/aac.01176-15Open DOISearch in Google Scholar
Matussek A, Mernelius S, Chromek M, Zhang J, Frykman A, Hansson S, Georgieva V, Xiong Y, Bai X. Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018. Eur J Clin Microbiol Infect Dis. 2023 Jun;42(6):771–779. https://doi.org/10.1007/s10096-023-04600-1MatussekAMerneliusSChromekMZhangJFrykmanAHanssonSGeorgievaVXiongYBaiX.Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018..2023Jun;42(6):771–779. https://doi.org/10.1007/s10096-023-04600-1Open DOISearch in Google Scholar
Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol. 2014 Jul;36(4):399–420. https://doi.org/10.1007/s00281-014-0416-xMeleCRemuzziGNorisM.Hemolytic uremic syndrome..2014Jul;36(4):399–420. https://doi.org/10.1007/s00281-014-0416-xOpen DOISearch in Google Scholar
Mühlen S, Dersch P. Treatment strategies for infections with Shiga toxin-producing Escherichia coli. Front Cell Infect Microbiol. 2020 May;10:169. https://doi.org/10.3389/fcimb.2020.00169MühlenSDerschP.Treatment strategies for infections with Shiga toxin-producing Escherichia coli..2020May;10:169. https://doi.org/10.3389/fcimb.2020.00169Open DOISearch in Google Scholar
Nielsen EM, Andersen MT. Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5’ nuclease PCR assay. J Clin Microbiol. 2003 Jul;41(7):2884–2893. https://doi.org/10.1128/jcm.41.7.2884-2893.2003NielsenEMAndersenMT.Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5’ nuclease PCR assay..2003Jul;41(7):2884–2893. https://doi.org/10.1128/jcm.41.7.2884-2893.2003Open DOISearch in Google Scholar
Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA. 2012 Mar;307(10):1046–1052. https://doi.org/10.1001/jama.2012.264NitschkeMSaykFHärtelCRoselandRTHauswaldtSSteinhoffJFellermannKDeradIWellhönerPBüningJ.Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4..2012Mar;307(10):1046–1052. https://doi.org/10.1001/jama.2012.264Open DOISearch in Google Scholar
Noris M, Bresin E, Mele C, Remuzzi G. Genetic atypical hemolytic uremic syndrome. [Internet, update 2021 Sep 23]. In: Adam MP, Mirzaa GM, Pagon RA et al., editors. GeneReviews®. Seattle (USA): University of Washington; 1993-2023 [cited 2023 Nov 30]. Available from https://www.ncbi.nlm.nih.gov/books/NBK1367/NorisMBresinEMeleCRemuzziG.Genetic atypical hemolytic uremic syndrome. [Internet, update 2021 Sep 23]. In:AdamMPMirzaaGMPagonRA., editors..Seattle (USA):University of Washington;1993-2023[cited 2023 Nov 30].Available from https://www.ncbi.nlm.nih.gov/books/NBK1367/Search in Google Scholar
Perelle S, Dilasser F, Grout J, Fach P. Detection by 5’-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world’s most frequent clinical cases. Mol Cell Probes. 2004 Jun;18(3):185–192. https://doi.org/10.1016/j.mcp.2003.12.004PerelleSDilasserFGroutJFachP.Detection by 5’-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world’s most frequent clinical cases..2004Jun;18(3):185–192. https://doi.org/10.1016/j.mcp.2003.12.004Open DOISearch in Google Scholar
Perelle S, Dilasser F, Grout J, Fach P. Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction. J Appl Microbiol. 2005;98(5): 1162–1168. https://doi.org/10.1111/j.1365-2672.2005.02545.xPerelleSDilasserFGroutJFachP.Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction..2005;98(5):1162–1168. https://doi.org/10.1111/j.1365-2672.2005.02545.xOpen DOISearch in Google Scholar
Prado V, Basualdo W, Arellano C, Martínez J, Levine MM. [In vitro susceptibility of enterohemorrhagic Escherichia coli to 11 antimicrobials. Relationship between antibiotic resistance and toxigenic genotype] (in Spanish). Rev Med Chil. 1995 Sep;123(9): 1085–1090.PradoVBasualdoWArellanoCMartínezJLevineMM.[In vitro susceptibility of enterohemorrhagic Escherichia coli to 11 antimicrobials..1995Sep;123(9):1085–1090.Search in Google Scholar
Rastawicki W, Śmietańska K, Rokosz-Chudziak N, Wolkowicz T. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland. Lett Appl Microbiol. 2020 Jun;70(6):440–446. https://doi.org/10.1111/lam.13295RastawickiWŚmietańskaKRokosz-ChudziakNWolkowiczT.Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland..2020Jun;70(6):440–446. https://doi.org/10.1111/lam.13295Open DOISearch in Google Scholar
Sallée M, Ismail K, Fakhouri F, Vacher-Coponat H, Moussi-Francés J, Frémaux-Bacchi V, Burtey S. Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome. BMC Nephrol. 2013 Jan;14:3. https://doi.org/10.1186/1471-2369-14-3SalléeMIsmailKFakhouriFVacher-CoponatHMoussi-FrancésJFrémaux-BacchiVBurteyS.Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome..2013Jan;14:3. https://doi.org/10.1186/1471-2369-14-3Open DOISearch in Google Scholar
Skinner C, Zhang G, Patfield S, He X. An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxinproducing Escherichia coli. Antimicrob Agents Chemother. 2015 Sep; 59(9):5435–5444. https://doi.org/10.1128/aac.00763-15SkinnerCZhangGPatfieldSHeX.An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxinproducing Escherichia coli..2015Sep;59(9):5435–5444. https://doi.org/10.1128/aac.00763-15Open DOISearch in Google Scholar
Tarr GAM, Oltean HN, Phipps AI, Rabinowitz P, Tarr PI. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition. Int J Med Microbiol. 2018 Oct;308(7):921–926. https://doi.org/10.1016/j.ijmm.2018.06.009TarrGAMOlteanHNPhippsAIRabinowitzPTarrPI.Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition..2018Oct;308(7):921–926. https://doi.org/10.1016/j.ijmm.2018.06.009Open DOISearch in Google Scholar
The Institut Pasteur. Enterohemorrhagic Escherichia coli (EHEC) [Internet]. Paris (France): Institut Pasteur; 2023 [cited 2023 Oct 30]. Available from https://www.pasteur.fr/en/medical-center/disease-sheets/enterohemorrhagic-escherichia-coli-ehecThe Institut Pasteur..Paris (France):Institut Pasteur;2023[cited 2023 Oct 30].Available from https://www.pasteur.fr/en/medical-center/disease-sheets/enterohemorrhagic-escherichia-coli-ehecSearch in Google Scholar
WHO.E. coli. [Internet]. Geneva (Switzerland): World Health Organization; 2018 [cited 2023 Oct 30]. Available from https://www.who.int/news-room/fact-sheets/detail/e-coliWHO.. [Internet].Geneva (Switzerland):World Health Organization;2018[cited 2023 Oct 30].Available from https://www.who.int/news-room/fact-sheets/detail/e-coliSearch in Google Scholar
Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: A multivariable analysis. Clin Infect Dis. 2012 Jul;55(1):33–41. https://doi.org/10.1093/cid/cis299WongCSMooneyJCBrandtJRStaplesAOJelacicSBosterDRWatkinsSLTarrPI.Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: A multivariable analysis..2012Jul;55(1):33–41. https://doi.org/10.1093/cid/cis299Open DOISearch in Google Scholar
Yoshii N, Ogura Y, Hayashi T, Ajiro T, Sameshima T, Nakazawa M, Kusumoto M, Iwata T, Akiba M. Pulsed-field gel electrophoresis profile changes resulting from spontaneous chromosomal deletions in enterohemorrhagic Escherichia coli O157:H7 during passage in cattle. Appl Environ Microbiol. 2009 Sep;75(17):5719–5726. https://doi.org/10.1128/aem.00558-09YoshiiNOguraYHayashiTAjiroTSameshimaTNakazawaMKusumotoMIwataTAkibaM.Pulsed-field gel electrophoresis profile changes resulting from spontaneous chromosomal deletions in enterohemorrhagic Escherichia coli O157:H7 during passage in cattle..2009Sep;75(17):5719–5726. https://doi.org/10.1128/aem.00558-09Open DOISearch in Google Scholar
Zhu W, Guo H, Xu J, Wu W, Yi Y, Wang J, Duan R, Tong J, Du Y. Enterohemorrhagic Escherichia coli O157:H7 – Xuzhou City, Jiangsu Province, China, 2001–2021. China CDC Wkly. 2023 Apr;5(14): 311–314. https://doi.org/10.46234/ccdcw2023.057ZhuWGuoHXuJWuWYiYWangJDuanRTongJDuY.Enterohemorrhagic Escherichia coli O157:H7 – Xuzhou City, Jiangsu Province, China, 2001–2021..2023Apr;5(14):311–314. https://doi.org/10.46234/ccdcw2023.057Open DOISearch in Google Scholar